DexCom Inc (DXCM) — Technical state
As of 2026-11-09 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 62 out of 100 (momentum 67 · quality 79 · valuation 34), as of 2026-11-11.
- Signal: In a correction — 12.4% off its high — 12.4% below its 52-week high and under its 50-day — a textbook 10-to-20% correction. (as of 2026-11-09)
- Trend: DexCom Inc trades 4.6% below its 50-day and 8.2% above its 200-day moving average. (as of 2026-11-09)
- Index seat: HALO Growth 100
DexCom designs and sells continuous glucose monitoring systems for people managing diabetes and metabolic conditions. Its range includes the Dexcom G7 and G6 sensors, the Dexcom ONE+ device meant to replace fingerstick testing, and Stelo, a biosensor for adults with prediabetes or Type 2 diabetes who do not use insulin.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the DXCM overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
12.4% below its 52-week high and under its 50-day — a textbook 10-to-20% correction.
The moving-average stack
- vs 20-day-1.7%
- vs 50-day-4.6%
- vs 200-day+8.2%
- 52-week band12.4% off the high · +49.8% off the low
- Streak1 consecutive up session
- 50-day crossprice crossed down through the 50-day 3 sessions ago
- Stochastic%K 37.3 · %D 54.8 · down cross
Continue: the DXCM chart & overview · quality & forensics · the earnings record · the signal board
FAQ · from the current data · as of 2026-11-09
Quick answers
What is the current Closelooknet signal on DXCM?
In a correction — 12.4% off its high — 12.4% below its 52-week high and under its 50-day — a textbook 10-to-20% correction. As of 2026-11-09; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is DXCM above its 50-day and 200-day moving averages?
As of 2026-11-09, DexCom Inc trades -4.6% below its 50-day and +8.2% above its 200-day average, with the 20-day -1.7% away.
How far is DXCM from its 52-week high?
12.4% below the 52-week high and 49.8% above the 52-week low, as of 2026-11-09.
Related in the Closelooknet universe
same Closelooknet index seat first, then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- RACE Ferrari NV
- LLY Eli Lilly and Company
- REGN Regeneron Pharmaceuticals Inc
- HDB HDFC Bank Limited ADR
- TOST Toast Inc
- GMED Globus Medical
- ONON On Holding Ltd
- VRSK Verisk Analytics Inc
- FAST Fastenal Company
- IDXX IDEXX Laboratories Inc
- ZEAL.CO Zealand Pharma A/S
- ERJ Embraer S.A.
- SECT-B.ST Sectra AB (publ)industry
- SNN Smith & Nephew SNATS Incindustry
- SOON.SW Sonova H Agindustry
- GKOS Glaukos Corpindustry
- SYK Stryker Corporationindustry
- GEHC GE HealthCare Technologies Inc.industry
- ENOV Enovis Corpindustry
- MED.SW Medartis Holding AGindustry